详情页 - 四川省肿瘤医院知识库

当前位置：首页 > 详情页

Demonstration program of population-based lung cancer screening in China: Rationale and study design.

文献详情

资源类型：

Pubmed体系：

作者：

机构： [1]Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Environment, Tianjin Lung Cancer Institute, Tianjin Medical University General Hospital,Tianjin, China [2]Department of Diagnostic Radiology, Chinese Academy of Medical Sciences, Peking Union Medical College, Cancer Hospital, Beijing, China [3]Department of Thoracic Surgery, the Third Affiliated Hospital of Kunming Medical College (Yunnan Tumor Hospital), Kunming, Yunnan, China [4]Department of Radiology, Tianjin Medical University General Hospital, Tianjin, China [5]Medical Oncology, Cancer Center,West China Hospital, Sichuan University, Chengdu, Sichuan, China [6]Department of Pathology, Tianjin Medical University General Hospital, Tianjin, China [7]Department of Respiratory Medicine,West China Hospital, Sichuan University, Chengdu, Sichuan, China [8]Department of Cancer Epidemiology, Cancer Institute, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

出处：

DOI：

ISSN：

摘要：

Lung cancer is the leading cause of cancer-related death and has become an enormous economic burden in China. Low-dose spiral computed tomography (LDCT) screening could reduce lung cancer mortality. The feasibility of conducting a population-based lung cancer screening with LDCT in China is uncertain. In 2010, a demonstration program of lung cancer screening was initiated in China. High-risk individuals were enrolled in a cluster sampling design in different centers. Participants received baseline and annual screening with spiral CT and follow-up information was collected. The objective of this program is to evaluate the feasibility of conducting population-based LDCT lung cancer screening in the Chinese context. The rates of detection, early diagnosis and treatment are defined as indicators of program performance. The optimal management strategies for nodules are explored in the Chinese context based on experiences in other studies overseas. A demonstration program of ongoing prospective, multi-center, population-based lung cancer screening is being performed in China. This demonstration program will provide opportunities to explore the feasibility of LDCT lung cancer screening in the Chinese setting.

基金：

语种：

PubmedID：

中科院(CAS)分区：

出版当年[2014]版：

大类 | 4 区医学

小类 | 4 区肿瘤学 4 区呼吸系统

最新[2023]版：

大类 | 3 区医学

小类 | 4 区肿瘤学 4 区呼吸系统

第一作者：

第一作者机构： [1]Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Environment, Tianjin Lung Cancer Institute, Tianjin Medical University General Hospital,Tianjin, China [*1]Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Environment, Tianjin Lung Cancer Institute, Tianjin Medical University General Hospital, No. 154 Anshan Street, Heping District, Tianjin 300052, China

通讯作者：

通讯机构： [1]Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Environment, Tianjin Lung Cancer Institute, Tianjin Medical University General Hospital,Tianjin, China [8]Department of Cancer Epidemiology, Cancer Institute, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China [*1]Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Environment, Tianjin Lung Cancer Institute, Tianjin Medical University General Hospital, No. 154 Anshan Street, Heping District, Tianjin 300052, China [*2]Department of Cancer Epidemiology, Cancer Institute, Chinese Academy of Medical Sciences and Peking Union Medical College, 17 South, Panjiayuan Lane, Beijing 10021, China

推荐引用方式(GB/T 7714)：

APA：

MLA：